The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy
Background At present, the discovery of new biomarkers is of great significance for the early diagnosis, treatment and prognosis assessment of ovarian cancer.Previous findings indicated that aberrant G-protein-coupled receptor 176 (GPR176) expression might contribute to tumorigenesis and subsequent progression.However, the expression of GPR176 and